STAT

Opinion: Tackling drug shortages with data, AI, legislation, and more

Drug shortages can have profound adverse consequences. Identifying their root causes and devising workable solutions for them will require a multi-stakeholder effort with more accountability and greater agility than we've…

Every quarter since 2014, roughly 150 to 300 drugs have been in short supply in the U.S. The drug shortages list has included injectable morphine and other painkillers, anesthetics, antibiotics, cancer drugs, medications for mental illness, and much more.

In June 2018, a bipartisan group of 31 U.S. senators and 104 members of the House of Representatives in hopes of addressing the nation’s drug shortage crisis. The had shown that the number of ongoing drug shortages was increasing, some lasting longer than eight years. done by the FDA in early 2020 found that while there have

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks